Triethylene Glycol

Triethylene Glycol

SCHEMBL8002283

CCO.OCCOCCOCCO

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Triethylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.79
KMT2A Q03164 4/20 0.79
TSHR P16473 4/20 0.71
MAPK1 P28482 2/20 0.71
ALDH1A1 P00352 6/20 0.65
THRB P10828 1/20 0.62
HTT P42858 1/20 0.62
MAPT P10636 1/20 0.62
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
CASP1 P29466 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SLCO1B3 Q9NPD5 1/20 0.38
SLCO1B1 Q9Y6L6 1/20 0.38
APP P05067 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetraethylene Glycol SCHEMBL14109914 1.00 MEN1 (0.79) MEN1KMT2ATSHRMAPK1ALDH1A1
Di(Hydroxyethyl)Ether SCHEMBL4067863 0.96 TSHR (0.77) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL7858578 0.94 MEN1 (0.69) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL10423729 0.93 MEN1 (0.79) MEN1KMT2ATSHRMAPK1ALDH1A1
Diethylene Glycol Monoethyl Ether SCHEMBL8014385 0.91 ALDH1A1 (0.82) MEN1KMT2ATSHRMAPK1ALDH1A1
Diethylene Glycol Monoethyl Ether SCHEMBL1123497 0.91 ALDH1A1 (0.82) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL1925152 0.91 ALDH1A1 (0.72) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL20266549 0.90 MEN1 (0.73) MEN1KMT2ATSHRMAPK1ALDH1A1
Tetraethylene Glycol SCHEMBL9839242 0.90 MEN1 (0.73) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL3918883 0.90 MEN1 (0.73) MEN1KMT2ATSHRMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2825286-A1 AMINE TREATING PROCESS FOR ACID GAS SEPARATION USING BLENDS OF AMINES AND ALKYLOXYAMINES ExxonMobil Research and Engineering Company (US) 2015-01-21 EP claimed
US-20130243676-A1 AMINE TREATING PROCESS FOR ACID GAS SEPARATION USING BLENDS OF AMINES AND ALKYLOXYAMINES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-09-19 US claimed
WO-2013138443-A1 AMINE TREATING PROCESS FOR ACID GAS SEPARATION USING BLENDS OF AMINES AND ALKYLOXYAMINES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2013-09-19 WO claimed
US-11981768-B2 Polyol component and use thereof for producing rigid polyurethane foams BASF SE (DE) 2024-05-14 US disclosed
EP-3941955-B1 POLYOL COMPONENT AND USE THEREOF FOR PRODUCING RIGID POLYURETHANE FOAMS BASF SE (DE) 2023-12-13 EP disclosed
US-11369919-B2 Absorbent for selective removal of hydrogen sulfide from a fluid stream BASF SE (DE) 2022-06-28 US disclosed
US-20220162372-A1 Polyol component and use thereof for producing rigid polyurethane foams BASF SE (DE) 2022-05-26 US disclosed
US-11286329-B2 Polyol component and use thereof for the production of rigid polyurethane foams BASF SE (DE) 2022-03-29 US disclosed
US-11278841-B2 Removal of hydrogen sulphide and carbon dioxide from a stream of fluid BASF SE (DE) 2022-03-22 US disclosed
EP-3941955-A1 POLYOL COMPONENT AND USE THEREOF FOR PRODUCING RIGID POLYURETHANE FOAMS BASF SE (DE) 2022-01-26 EP disclosed
US-20210309790-A1 Polyol component and use thereof for the production of rigid polyurethane foams BASF SE (DE) 2021-10-07 US disclosed
CN-101313032-B Light-blocking resin composition, color filter and liquid crystal display device MITSUBISHI CHEM CORP 2011-04-06 CN disclosed
CN-101326454-B Method for manufacturing polarizing plate, polarizing plate and liquid crystal display device KONICA MINOLTA OPTO INC 2010-11-03 CN disclosed
CN-101326454-A Method for manufacturing polarizing plate, polarizing plate and liquid crystal display device KONICA MINOLTA OPTO INC (JP) 2008-12-17 CN disclosed
CN-101313032-A Light-blocking resin composition, color filter and liquid crystal display device MITSUBISHI CHEM CORP (JP) 2008-11-26 CN disclosed
US-6150452-A PAPERMAKING BETZDEARBORN INC. (US) 2000-11-21 US disclosed
EP-0986670-A4 METHODS AND COMPOSITIONS FOR TREATING STICKIES BETZDEARBORN INC (US) 2000-08-23 EP disclosed
EP-0986670-A1 METHODS AND COMPOSITIONS FOR TREATING STICKIES BetzDearborn Inc (US) 2000-03-22 EP disclosed
US-5936024-A TREATING THE PAPERMAKING FIBER WITH AN OIL-SOLUBLE OR WATER-DISPERSIBLE MIXTURE OF AT LEAST TWO OF HYDROPHOBIC POLYMER, A SURFACTANT HAVING AN HLB OF ABOUT 1 TO ABOUT 10, A TACKIFIER AND ASOLVENT; MECHANICALLY SEPARATING BETZDEARBORN INC. (US) 1999-08-10 US disclosed
WO-1998055692-A1 METHODS AND COMPOSITIONS FOR TREATING STICKIES BETZDEARBORN INC. (US) 1998-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11278841-B2 Removal of hydrogen sulphide and carbon dioxide from a stream of fluid C1R, MSRB3, HRH4 MEN1 3400/4885KMT2A 3438/4885TSHR 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.